Related Experiment Video
Updated: Jul 28, 2026

Detection of Toxin Translocation into the Host Cytosol by Surface Plasmon Resonance
Published on: January 3, 2012
Glucosylation of Rho proteins by Clostridium difficile toxin B
1Institut für Pharmakologie und Toxikologie, Universität des Saarlandes, Homburg/Saar, Germany.
Abstract:
Toxin A and B, the major virulence factors of Clostridium difficile, are the causative agents of antibiotic-associated pseudomembranous colitis. In cultured cell lines their potent cytotoxicity results from their ability to induce disaggregation of the microfilament cytoskeleton. Toxin B acts on the low-molecular-mass GTPase RhoA, which is involved in the regulation of the actin cytoskeleton. We report here that toxin B catalyses the incorporation of up to one mole of glucose per mole of RhoA at the amino acid threonine at position 37. The modification was identified and localized by tandem electrospray mass spectrometry. UDP-glucose selectively serves as cosubstrate for the monoglucosylation reaction catalysed by toxin B. Microinjection of RhoA previously glucosylated by toxin B into monolayer cells caused disaggregation of actin filaments, indicating a dominant-negative activity of glucosylated RhoA.
Insights
Clostridium difficile toxin B modifies RhoA GTPase by adding glucose, inactivating it. This glucosylated RhoA disrupts the actin cytoskeleton, causing cell damage and contributing to colitis.
Area of Science:
- Microbiology
- Cell Biology
- Biochemistry
Background:
- Clostridium difficile toxins A and B cause antibiotic-associated colitis.
- These toxins induce cytotoxicity by disaggregating the microfilament cytoskeleton.
- Toxin B targets the RhoA GTPase, crucial for actin cytoskeleton regulation.
Purpose of the Study:
- To investigate the specific mechanism by which Clostridium difficile toxin B affects RhoA.
- To identify the modification and its effect on RhoA function.
Main Methods:
- Tandem electrospray mass spectrometry was used to identify and localize the modification.
- UDP-glucose was used as a cosubstrate in vitro.
- Microinjection of modified RhoA into cultured cells.
Main Results:
- Toxin B catalyzes the monoglucosylation of RhoA at threonine 37.
- UDP-glucose serves as the selective cosubstrate for this monoglucosylation.
- Microinjected glucosylated RhoA caused actin filament disaggregation, demonstrating dominant-negative activity.
Conclusions:
- Clostridium difficile toxin B inactivates RhoA through monoglucosylation.
- This modification disrupts the actin cytoskeleton, contributing to the toxin's cytotoxic effects.
- Targeting this glucosylation mechanism may offer therapeutic strategies against C. difficile infections.
More Related Videos
Related Concept Videos
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Protein Folding Quality Check in the RER
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GPCRs Regulate Adenylyl Cylase Activity
Two...
Bacterial Toxins
Diphtheria

